Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 40

Cited In for PubMed (Select 12019661)


Development and application of an aggregate adherence metric derived from population pharmacokinetics to inform clinical trial enrichment.

Knights J, Rohatagi S.

J Pharmacokinet Pharmacodyn. 2015 Jun;42(3):263-73. doi: 10.1007/s10928-015-9414-4. Epub 2015 Mar 29.


Trajectories of medication attitudes and adherence behavior change in non-adherent bipolar patients.

Levin JB, Tatsuoka C, Cassidy KA, Aebi ME, Sajatovic M.

Compr Psychiatry. 2015 Apr;58:29-36. doi: 10.1016/j.comppsych.2014.11.023. Epub 2014 Dec 27.


Perspectives on reasons of medication nonadherence in psychiatric patients.

Mert DG, Turgut NH, Kelleci M, Semiz M.

Patient Prefer Adherence. 2015 Jan 13;9:87-93. doi: 10.2147/PPA.S75013. eCollection 2015.


Individualized texting for adherence building (iTAB): improving antiretroviral dose timing among HIV-infected persons with co-occurring bipolar disorder.

Moore DJ, Poquette A, Casaletto KB, Gouaux B, Montoya JL, Posada C, Rooney AS, Badiee J, Deutsch R, Letendre SL, Depp CA, Grant I, Atkinson JH; HIV Neurobehavioral Research Program (HNRP) Group.

AIDS Behav. 2015 Mar;19(3):459-71. doi: 10.1007/s10461-014-0971-0.


Psychotherapy of mood disorders.

Picardi A, Gaetano P.

Clin Pract Epidemiol Ment Health. 2014 Nov 26;10:140-58. doi: 10.2174/1745017901410010140. eCollection 2014.


Compliance as a stable function in the treatment course of bipolar disorder in patients stabilized on olanzapine: results from a 24-month observational study.

Kutzelnigg A, Kopeinig M, Chen CK, Fábián A, Pujol-Luna MG, Shin YC, Treuer T, D'yachkova Y, Deix C, Kasper S, Doby D.

Int J Bipolar Disord. 2014 Oct 23;2(1):13. eCollection 2014 Dec.


Knowledge of and Attitudes Towards Behavioral Health Services Among Older Youth in the Foster Care System.

Munson MR, Narendorf SC, McMillen JC.

Child Adolesc Social Work J. 2011 Apr 1;28(2):97-112.


Correlates of attitudes towards mood stabilizers in individuals with bipolar disorder.

Chang CW, Sajatovic M, Tatsuoka C.

Bipolar Disord. 2015 Feb;17(1):106-12. doi: 10.1111/bdi.12226. Epub 2014 Jun 26.


Patient choice as a driver of medication-switching in non-adherent individuals with bipolar disorder.

Sajatovic M, Tatsuoka C, Dines P, Bialko CS, Athey M, Williams T, Cassidy KA.

Patient Prefer Adherence. 2014 Apr 17;8:487-91. doi: 10.2147/PPA.S56790. eCollection 2014.


Seeking insights about cycling mood disorders via anonymized search logs.

Yom-Tov E, White RW, Horvitz E.

J Med Internet Res. 2014 Feb 25;16(2):e65. doi: 10.2196/jmir.2664.


Prospective trial of customized adherence enhancement plus long-acting injectable antipsychotic medication in homeless or recently homeless individuals with schizophrenia or schizoaffective disorder.

Sajatovic M, Levin J, Ramirez LF, Hahn DY, Tatsuoka C, Bialko CS, Cassidy KA, Fuentes-Casiano E, Williams TD.

J Clin Psychiatry. 2013 Dec;74(12):1249-55. doi: 10.4088/JCP.12m08331.


Feasibility and Acceptability of a Mobile Intervention to Improve Treatment Adherence in Bipolar Disorder: A Pilot Study.

Wenze SJ, Armey MF, Miller IW.

Behav Modif. 2014 Jan 8;38(4):497-515. [Epub ahead of print]


Prospective, open-label trial measuring satisfaction and convenience of two formulations of lamotrigine in subjects with mood disorders.

Sajatovic M, Thompson TR, Nanry K, Edwards S, Manjunath R.

Patient Prefer Adherence. 2013 May 7;7:411-7. doi: 10.2147/PPA.S40271. Print 2013.


Suboptimal treatment adherence in bipolar disorder: impact on clinical outcomes and functioning.

Montes JM, Maurino J, de Dios C, Medina E.

Patient Prefer Adherence. 2013;7:89-94. doi: 10.2147/PPA.S39290. Epub 2013 Jan 18.


Short-term clinical stability and lack of insight are associated with a negative attitude towards antipsychotic treatment at discharge in patients with schizophrenia and bipolar disorder.

Medina E, Salvà J, Ampudia R, Maurino J, Larumbe J.

Patient Prefer Adherence. 2012;6:623-9. doi: 10.2147/PPA.S34345. Epub 2012 Aug 29.


Approaches to identifying appropriate medication adherence assessments for HIV infected individuals with comorbid bipolar disorder.

Badiee J, Riggs PK, Rooney AS, Vaida F, Grant I, Atkinson JH, Moore DJ; Hiv Neurobehavioral Research Program (HNRP) Group.

AIDS Patient Care STDS. 2012 Jul;26(7):388-94. doi: 10.1089/apc.2011.0447. Epub 2012 Jun 11.


Six-month outcomes of customized adherence enhancement (CAE) therapy in bipolar disorder.

Sajatovic M, Levin J, Tatsuoka C, Micula-Gondek W, Fuentes-Casiano E, Bialko CS, Cassidy KA.

Bipolar Disord. 2012 May;14(3):291-300. doi: 10.1111/j.1399-5618.2012.01010.x.


HIV-infected individuals with co-occurring bipolar disorder evidence poor antiretroviral and psychiatric medication adherence.

Moore DJ, Posada C, Parikh M, Arce M, Vaida F, Riggs PK, Gouaux B, Ellis RJ, Letendre SL, Grant I, Atkinson JH; HIV Neurobahavioral Research Program (HNRP).

AIDS Behav. 2012 Nov;16(8):2257-66. doi: 10.1007/s10461-011-0072-2.


Poor response to treatment: beyond medication.

Carvajal C.

Dialogues Clin Neurosci. 2004 Mar;6(1):93-103.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk